Manganese-stimulated redox cycling of dopamine derivatives: Implications for manganism
Manganism, the condition caused by chronic exposure to high levels of manganese, selectively targets the dopamine-rich basal ganglia causing a movement disorder with symptoms similar to Parkinson’s disease. While the basis for this specific targeting is unknown, we hypothesize that it may involve co...
Saved in:
Published in: | Neurotoxicology (Park Forest South) Vol. 90; pp. 10 - 18 |
---|---|
Main Authors: | , , , , , , , , |
Format: | Journal Article |
Language: | English |
Published: |
Netherlands
Elsevier B.V
01-05-2022
Elsevier BV |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Manganism, the condition caused by chronic exposure to high levels of manganese, selectively targets the dopamine-rich basal ganglia causing a movement disorder with symptoms similar to Parkinson’s disease. While the basis for this specific targeting is unknown, we hypothesize that it may involve complexation of Mn by dopamine derivatives. At micromolar concentrations, MnCl2 accelerates the two-equivalent redox cycling of a dopamine-derived benzothiazine (dopathiazine) by an order of magnitude. In the process, O2 is reduced to superoxide and hydrogen peroxide. This effect is unique to Mn and is not shared by Fe, Cu, Zn, Co, Ca or Mg. Notably, the effect of Mn requires the presence of inorganic phosphate, suggesting that phosphate may stabilize a Mn/catecholate complex, which reacts readily with O2. This or similar endogenous dopamine derivatives may exacerbate Mn-dependent oxidative stress accounting for the neurological selectivity of manganism.
[Display omitted]
•DTZ-2 represents a novel class of dopamine derivatives: dopathiazines.•Redox cycling of DTZ-2 is enhanced by Mn at micromolar concentrations.•Mn accelerates the reaction of reduced DTZ-2 with O2 to form H2O2.•Reduced dopathiazines probably form a coordination complex with Mn.•Dopathiazines may account for the selective neurological effects of chronic manganese exposure. |
---|---|
ISSN: | 0161-813X 1872-9711 |
DOI: | 10.1016/j.neuro.2022.02.007 |